Open AccessClinical Impact of Semaglutide, a Glucagon-Like Peptide-1 Receptor Agonist, on Obesity Management: A Review
Author(s) -
Nasser M. Alorfi,
Alanood S. Algarni
Publication year - 2022
Publication title -
clinical pharmacology advances and applications
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.685
H-Index - 27
ISSN - 1179-1438
DOI - 10.2147/cpaa.s374741
Subject(s) - semaglutide , medicine , adverse effect , weight loss , obesity , appetite , overweight , endocrinology , liraglutide , pharmacology , type 2 diabetes , diabetes mellitus
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom